Examples of using Postdose in English and their translations into Swedish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
-
Political
5-FU were quantifiable through 10 hours postdose.
Subjects were followed up to 67 months postdose 3 with a median duration of 43 months postdose 3.
In the vaccine group, 99.1 to 100% became seropositive to all vaccine serotypes by 1 month Postdose 3.
Micrograms/mL(Cmax) at 0.5 hour postdose(end of infusion), 7.0 micrograms/mL at 12 hour postdose, and 1.1 microgram/mL at 24 hour postdose.
protection has been observed postdose 3 in the PPE population.
Micrograms/mL(Cmax) at 0.5 hour postdose(end of infusion), 12.8 micrograms/mL at 6 hour postdose, and 3.0 micrograms/mL at 12 hour postdose.
respectively, by 1 month Postdose 3.
Table 7 compares the 1 month Postdose 3 anti-HPV 6,
Average concentrations of ertapenem in urine exceed 984 micrograms/ ml during the period 0 to 2 hours postdose and exceed 52 micrograms/ ml during the period 12 to 24 hours post-administration.
reach a peak between 12 and 18 hours postdose.
Steady state area under plasma concentration-time curve from time 0 to 8 hours postdose Ae% Percent of dose excreted unchanged into the urine from time 0 to 8 hours postdose NA Not available.
in whom case counting started at 1 month Postdose 1.
Persistence of antibody response(postdose 3) has been observed for 10 years in adolescents who were 9-15 years of age at time of vaccination;
administration of Teysuno in man, maximum uracil concentrations reflecting DPD inhibition were observed approximately 4 hours postdose.
at 0.5 hour postdose(end of infusion), and 6.2 micrograms/ ml at 12 hour postdose.
respectively, by 1 month Postdose 3.
at 0.5 hour postdose(end of infusion), 12.8 micrograms/ ml at 6 hour postdose, and 3.0 micrograms/ ml at 12 hour postdose.
respectively, by 1 month Postdose 3.
at 0.5 hour postdose(end of infusion), 7.0 micrograms/ ml at 12 hour postdose, and 1.1 microgram/ ml at 24 hour postdose.
anti-HPV 11, anti-HPV 16, and anti-HPV 18-seropositive, respectively, by 1 month Postdose 3.
at 0.5 hour postdose(end of infusion), 13.5 micrograms/ ml at 6 hour postdose, and 2.5 micrograms/ ml at 12 hour postdose.
strong anamnestic response that exceeded the anti-HPV GMTs observed 1 month Postdose 3.
anti-HPV 18-seropositive respectively, by 1 month Postdose 3 across all age groups tested.
through 1 month Postdose 3 Month 7.
naïve to the relevant HPV type(s) prior to dose 1 and through 1 month Postdose 3 Month 7.
naïve to the relevant HPV type(s) prior to dose 1 and through 1 month Postdose 3 Month 7.